Skip to main content
Top
Published in: Cancer Cell International 1/2024

Open Access 01-12-2024 | Colorectal Cancer | Research

C6orf15 promotes liver metastasis via WNT/β-catenin signalling in colorectal cancer

Authors: Jiankang Yu, Jian Sun, Jingtong Tang, Jiayu Xu, Guanru Qian, Jianping Zhou

Published in: Cancer Cell International | Issue 1/2024

Login to get access

Abstract

Background

Colon cancer ranks third among global tumours and second in cancer-related mortality, prompting an urgent need to explore new therapeutic targets. C6orf15 is a novel gene that has been reported only in Sjogren’s syndrome and systemic lupus erythematosus patients. We found a close correlation between increased C6orf15 expression and the occurrence of colon cancer. The aim of this study was to explore the potential of C6orf15 as a therapeutic target for colorectal cancer.

Method

RNA-seq differential expression analysis of the TCGA database was performed using the R package ‘limma.’ The correlation between target genes and survival as well as tumour analysis was analysed using GEPIA. Western blot and PCR were used to assess C6orf15 expression in colorectal cancer tissue samples. Immunofluorescence and immunohistochemistry were used to assess C6orf15 subcellular localization and tissue expression. The role of C6orf15 in liver metastasis progression was investigated via a mouse spleen infection liver metastasis model. The association of C6orf15 with signalling pathways was assessed using the GSEA-Hallmark database. Immunohistochemistry (IHC), qPCR and western blotting were performed to assess the expression of related mRNAs or proteins. Biological characteristics were evaluated through cell migration assays, MTT assays, and Seahorse XF96 analysis to monitor fatty acid metabolism.

Results

C6orf15 was significantly associated with liver metastasis and survival in CRC patients as determined by the bioinformatic analysis and further verified by immunohistochemistry (IHC), qPCR and western blot results. The upregulation of C6orf15 expression in CRC cells can promote the nuclear translocation of β-catenin and cause an increase in downstream transcription. This leads to changes in the epithelial–mesenchymal transition (EMT) and alterations in fatty acid metabolism, which together promote liver metastasis of CRC.

Conclusion

Our study identified C6orf15 as a marker of liver metastasis in CRC. C6orf15 can activate the WNT/β-catenin signalling pathway to promote EMT and fatty acid metabolism in CRC.
Appendix
Available only for authorised users
Literature
6.
go back to reference Chung SA, Brown EE, Williams AH, Ramos PS, Berthier CC, Bhangale T, Alarcon-Riquelme ME, Behrens TW, Criswell LA, Graham DC, Demirci FY, Edberg JC, Gaffney PM, Harley JB, Jacob CO, Kamboh MI, Kelly JA, Manzi S, Moser-Sivils K, Russell LP, Petri M, Tsao BP, Vyse TJ, Zidovetzki R, Kretzler M, Kimberly RP, Freedman BI, Graham RR, Langefeld CD, International Consortium for Systemic Lupus Erythematosus Genetics. Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. J Am Soc Nephrol. 2014;25(12):2859–70. https://doi.org/10.1681/ASN.2013050446.CrossRefPubMedPubMedCentral Chung SA, Brown EE, Williams AH, Ramos PS, Berthier CC, Bhangale T, Alarcon-Riquelme ME, Behrens TW, Criswell LA, Graham DC, Demirci FY, Edberg JC, Gaffney PM, Harley JB, Jacob CO, Kamboh MI, Kelly JA, Manzi S, Moser-Sivils K, Russell LP, Petri M, Tsao BP, Vyse TJ, Zidovetzki R, Kretzler M, Kimberly RP, Freedman BI, Graham RR, Langefeld CD, International Consortium for Systemic Lupus Erythematosus Genetics. Lupus nephritis susceptibility loci in women with systemic lupus erythematosus. J Am Soc Nephrol. 2014;25(12):2859–70. https://​doi.​org/​10.​1681/​ASN.​2013050446.CrossRefPubMedPubMedCentral
11.
go back to reference Sánchez-Tilló E, Siles L, De Barrios O, Cuatrecasas M, Vaquero EC, Castells A, Postigo A. Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J Cancer Res. 2011;1(7):897–912.PubMedPubMedCentral Sánchez-Tilló E, Siles L, De Barrios O, Cuatrecasas M, Vaquero EC, Castells A, Postigo A. Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J Cancer Res. 2011;1(7):897–912.PubMedPubMedCentral
14.
go back to reference Jing Q, Can C, Yue T, Nian J, Chaoliang L, Weihua L, Ya C, Xiangjian L. Acyl-CoA synthetase long-chain 3-mediated fatty acid oxidation is required for TGFβ1-induced epithelial-mesenchymal transition and metastasis of colorectal carcinoma. Int J Biol Sci. 2022;18(6):2484–96. https://doi.org/10.7150/ijbs.69802.CrossRef Jing Q, Can C, Yue T, Nian J, Chaoliang L, Weihua L, Ya C, Xiangjian L. Acyl-CoA synthetase long-chain 3-mediated fatty acid oxidation is required for TGFβ1-induced epithelial-mesenchymal transition and metastasis of colorectal carcinoma. Int J Biol Sci. 2022;18(6):2484–96. https://​doi.​org/​10.​7150/​ijbs.​69802.CrossRef
15.
go back to reference Weixing D, Wenqiang X, Lingyu H, Zixu Y, Renjie W, Yanlei Ma, Yongzhi Y, Sanjun C, Ye Xu, Shaobo Mo, Qingguo Li, Guoxiang C. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism. Cancer Commun (Lond). 2022;42(9):848–67. https://doi.org/10.1002/cac2.12341.CrossRef Weixing D, Wenqiang X, Lingyu H, Zixu Y, Renjie W, Yanlei Ma, Yongzhi Y, Sanjun C, Ye Xu, Shaobo Mo, Qingguo Li, Guoxiang C. PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism. Cancer Commun (Lond). 2022;42(9):848–67. https://​doi.​org/​10.​1002/​cac2.​12341.CrossRef
24.
go back to reference Kyu KW, Yujin K, Mi J, Minhee P, Jiyoon K, Suyeon C, Geon JD, Wook-Bin L, Hoon JS, Jin CH, Soh MB, Tae IK, Pil HS, Young-Ki P, Hoguen K. β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers. Sci Rep. 2019;9(1):18440. https://doi.org/10.1038/s41598-019-54890-9.CrossRef Kyu KW, Yujin K, Mi J, Minhee P, Jiyoon K, Suyeon C, Geon JD, Wook-Bin L, Hoon JS, Jin CH, Soh MB, Tae IK, Pil HS, Young-Ki P, Hoguen K. β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers. Sci Rep. 2019;9(1):18440. https://​doi.​org/​10.​1038/​s41598-019-54890-9.CrossRef
25.
go back to reference Larion S, Garrett D, Dongwen W, Fang-Ming D, Peng L. Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment. Am J Cancer Res. 2017;7(6):1389–406. Larion S, Garrett D, Dongwen W, Fang-Ming D, Peng L. Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment. Am J Cancer Res. 2017;7(6):1389–406.
Metadata
Title
C6orf15 promotes liver metastasis via WNT/β-catenin signalling in colorectal cancer
Authors
Jiankang Yu
Jian Sun
Jingtong Tang
Jiayu Xu
Guanru Qian
Jianping Zhou
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2024
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-024-03324-2

Other articles of this Issue 1/2024

Cancer Cell International 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine